Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-12-000235
Filing Date
2012-02-14
Accepted
2012-02-14 15:13:29
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 form5-02142012_120217.html 5  
1 form5-02142012_120217.xml 5 9262
  Complete submission text file 0001415889-12-000235.txt   10638
Mailing Address 11011 Q STREET BUILDING A SUITE 106 OMAHA NE 68137
Business Address 11011 Q STREET BUILDING A SUITE 106 OMAHA NE 68137 402-884-1894
BOND LABORATORIES, INC. (Issuer) CIK: 0001374328 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 11011 Q STREET BUILDING A, SUITE 106 OMAHA NE 68137
Business Address
WILSON JOHN S (Reporting) CIK: 0001497703 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-52369 | Film No.: 12608458